Omeros | OMER - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Adma Biologics USD 49.38M 12.95M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Cytokinetics USD -183.03M 123.15M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Immunic USD -24.37M 2.99M 2024-09
Insmed USD -328.48M 41.54M 2025-12
Knight Therapeutics CAD -3.79M 8.83M 2025-09
MacroGenics USD -14.16M 30.98M 2025-12
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 1.64M 3.8M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Rockwell Medical USD 343K 2.07M 2024-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xoma USD -17.24M 33.23M 2024-09